Skip to main content
Clinical Trials/CTRI/2024/01/062135
CTRI/2024/01/062135
Recruiting
Phase 4

A Clinical Study to evaluate the moisturization potential of Piramal Lacto Calamine Light Moisturising Gel. - NI

Piramal Pharma Limited0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Piramal Pharma Limited
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Voluntary man or women between 18 and 65 years.
  • 2\. Photo type III to V.
  • 3\. Having apparently healthy skin on test area
  • 4\. For whom the investigator considers that the compliance will be correct.
  • 5\. Cooperating informed of the need and duration of the examinations and ready to comply with protocol procedures.
  • 6\. Having signed a Consent Form.
  • 7\. Willingness to avoid intense UV exposure on test site(sun or artificial UV) during the course of the study.
  • 8\. Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna) during the course of the study.
  • 9\. Should be able to read and write (in English, Hindi or local language).
  • 10\. Having valid proof of identity and age.

Exclusion Criteria

  • 1\. Pregnant or nursing mothers
  • 2\.Scars, excessive terminal hair or tattoo on the studied area.
  • 3\.Henna tattoo anywhere on the body (in case of studies involving hair dyes).
  • 4\.Dermatological infection or pathology on the level of studied area.
  • 5\.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye).
  • 6\.Any clinically significant systemic or cutaneous disease which may interfere with study treatment or procedures.
  • 7\.Chronic illness which may influence the outcome of the study.
  • 8\.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).
  • 9\.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials